These modifications are often reversible and can control the expression, activity, and stability of the NRF2 gene, as well as its interactions with other regulatory elements within the cell
This is significant because MASLD/MASH affects an estimated 30% of the global population, and we currently have very limited pharmacological options
For Kansas City residents requiring significant weight reduction, or for those who have shown limited response to single-agonist treatments, Zepbound presents a potent alternative
Epigenetic-modifying therapies: an emerging avenue for the treatment of inflammatory skin diseases
Individual differences in absorption and metabolism could contribute to the variability observed in GLP-1 responses across study participants
ASCVD is defined somewhat differently across trials, but all trials enrolled individuals with established CVD (e.g